Diagnostic and prognostic impact of urinary catecholamines in neuroblastoma patients.
about
123I-MIBG scintigraphy and 18F-FDG-PET imaging for diagnosing neuroblastomaMIBG scintigraphy and PET imaging for diagnosing neuroblastomaMalignant tumours of the kidney: imaging strategy.Selective extraction of catecholamines by packed fiber solid-phase using composite nanofibers composing of polymeric crown ether with polystyrene.Avoiding misdiagnosing neuroblastoma as Wilms tumorClinical significance of serum biomarkers in pediatric solid mediastinal and abdominal tumors.Prognostic value of ferritin, neuron-specific enolase, lactate dehydrogenase, and urinary and plasmatic catecholamine metabolites in children with neuroblastomaTreatment of localised resectable neuroblastoma. Results of the LNESG1 study by the SIOP Europe Neuroblastoma Group.Metastatic orbital tumors in southern China during an 18-year period.Neuroblastoma: the impact of biology and cooperation leading to personalized treatments.Case report: value of gene expression profiling in the diagnosis of atypical neuroblastoma.Pediatric reference intervals for plasma free and total metanephrines established with a parametric approach: relevance to the diagnosis of neuroblastoma.Neuroblastoma presenting like a Wilms' tumor with thrombus in inferior vena cava and pulmonary metastases: a case series.The prognostic significance of vanillylmandellic acid in neuroblastoma.Individualized risk assessment in neuroblastoma: does the tumoral metabolic activity on 123I-MIBG SPECT predict the outcome?L-DOPA therapy interferes with urine catecholamine analysis in children with suspected neuroblastoma: a case series.Clinical validation of urine 3-methoxytyramine as a biomarker of neuroblastoma and comparison with other catecholamine-related biomarkers.Thin-layer chromatography--an image-processing method for the determination of acidic catecholamine metabolites.Adult renal neuroblastoma: A case report and literature review.
P2860
Q24186888-B0FB9D8D-EE36-4430-9FFE-AADFC7DD24E6Q24234571-16E88EBE-9F8F-4E73-96A9-25C144E07BC6Q33819087-8013C985-01F8-4576-BAE1-16EA191493D7Q35185211-07AB1FA9-AC1D-4AC6-AF22-6495517A907FQ35546537-3F521C55-A4C6-4136-B7C0-9220E1669C18Q35719602-7015F59E-56A3-47C3-A636-F291A97FA0ECQ36446812-F41D22E6-1415-4EDB-AD52-D0C6B1FBB2C2Q36936057-EA595C69-A645-4FC7-8FE9-9BE218FA44F3Q37862128-4B6D030D-5D3B-4270-9413-733B7402653EQ38014527-3B580842-2D25-4199-AB21-8C1575478E09Q38619616-67BFBCA2-B14E-4FE9-9950-102DBC437460Q41567179-28BDE138-17F1-4FC0-8A68-6EE0B9521411Q42615007-FCD146BE-0EE4-42D0-ABEE-799608FC4FF1Q43005393-BA8DF356-172C-492F-8D64-609F1FDB1900Q48238960-0995BC30-5109-410B-BED3-8D8DA2ECD398Q51015558-1F5DDCD2-46DE-4AA4-88CD-0D67AA56E0ABQ53092963-A042AD36-C26D-4F68-B012-DBD4D798BA70Q54352175-EEF15A61-1E03-4744-87AC-425CCB603556Q55302892-0E75B43B-30E8-4984-B42F-8B92E3F8AEA5
P2860
Diagnostic and prognostic impact of urinary catecholamines in neuroblastoma patients.
description
2007 nî lūn-bûn
@nan
2007 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Diagnostic and prognostic impact of urinary catecholamines in neuroblastoma patients.
@ast
Diagnostic and prognostic impact of urinary catecholamines in neuroblastoma patients.
@en
Diagnostic and prognostic impact of urinary catecholamines in neuroblastoma patients.
@nl
type
label
Diagnostic and prognostic impact of urinary catecholamines in neuroblastoma patients.
@ast
Diagnostic and prognostic impact of urinary catecholamines in neuroblastoma patients.
@en
Diagnostic and prognostic impact of urinary catecholamines in neuroblastoma patients.
@nl
prefLabel
Diagnostic and prognostic impact of urinary catecholamines in neuroblastoma patients.
@ast
Diagnostic and prognostic impact of urinary catecholamines in neuroblastoma patients.
@en
Diagnostic and prognostic impact of urinary catecholamines in neuroblastoma patients.
@nl
P2093
P356
P1476
Diagnostic and prognostic impact of urinary catecholamines in neuroblastoma patients.
@en
P2093
Christian Urban
Hans Jürgen Dornbusch
Inge M Ambros
Reinhold Kerbl
Ruth Ladenstein
Volker Strenger
P2860
P304
P356
10.1002/PBC.20888
P577
2007-05-01T00:00:00Z